Hengli Petrochemical (600346.SH): Restructuring matters approved through anti-monopoly review.

01/11/2023

Connect global capital markets.

"Hengli Petrochemical (600346.SH) Announcement: Recently, the company received a Notice of Decision from the State Administration for Market Regulation, stating that the further review of the concentration of business operators in the case of Hengli Petrochemical's acquisition of Dalian Thermal Power Co., Ltd.'s equity will not be implemented. The specific content is as follows: "According to Article 30 of the Anti-Monopoly Law of the People's Republic of China, after preliminary review, it is now decided that no further review will be conducted on the Hengli Petrochemical Co., Ltd.'s acquisition of Dalian Thermal Power Co., Ltd.'s equity. Your company can proceed with the concentration from now on. The case involves matters other than the antitrust review of business concentration, which shall be handled in accordance with relevant laws."

HK Stock Market Move | Gambling stocks continue to rise, Macau's gambling revenue in June exceeded expectations, Citigroup expects the growth momentum to continue in the second half of the year.

HK Stock Market Move | XINYI ENERGY (03868) surged more than 56% during trading. Earlier announced listing of CECEP Solar Energy power station REIT will help improve the company's financial situation.

HK Stock Market Move | CSTONE PHARMA-B(02616) rose by more than 7%, revealing for the first time the targets of the two bispecific antibody drugs CS2013 and CS2015.

HK Stock Market Move | Gambling stocks continue to rise, Macau's gambling revenue in June exceeded expectations, Citigroup expects the growth momentum to continue in the second half of the year.

HK Stock Market Move | CSTONE PHARMA-B(02616) rose by more than 7%, revealing for the first time the targets of the two bispecific antibody drugs CS2013 and CS2015.